Invention Grant
- Patent Title: Mycobacterial antigens expressed during latency
- Patent Title (中): 分枝杆菌抗原在潜伏期间表达
-
Application No.: US13214776Application Date: 2011-08-22
-
Publication No.: US08399650B2Publication Date: 2013-03-19
- Inventor: Brian W. James , Philip Marsh , Tobias Hampshire
- Applicant: Brian W. James , Philip Marsh , Tobias Hampshire
- Applicant Address: GB Salisbury
- Assignee: Health Protection Agency
- Current Assignee: Health Protection Agency
- Current Assignee Address: GB Salisbury
- Agency: Evan Law Group LLC
- Priority: GB0116385.6 20010704; GB0123993.8 20011005
- Main IPC: C07H21/04
- IPC: C07H21/04 ; A61K39/04 ; A61K39/02

Abstract:
A method is provided for identifying mycobacterial genes that are induced or up-regulated under culture conditions that are nutrient-starving and which maintain mycobacterial latency, said conditions being obtainable by batch fermentation of a mycobacterium for at least 20 days post-inoculation, when compared with culture conditions that are not nutrient-starving and which support exponential growth of said mycobacterium. Said induced or up-regulated genes form the basis of nucleic acid vaccines, or provide targets to allow preparation of attenuated mycobacteria for vaccines against mycobacterial infections. Similarly, peptides encoded by said induced or up-regulated genes are employed in vaccines. In a further embodiment, the identified genes/peptides provide the means for identifying the presence of a mycobacterial infection in a clinical sample by nucleic acid probe or antibody detection.
Public/Granted literature
- US20120034689A1 MYCOBACTERIAL ANTIGENS EXPRESSED DURING LATENCY Public/Granted day:2012-02-09
Information query